1. The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children 
Jeffrey Hyams, James Markowitz, Trudy Lerer, Anne Griffiths, David Mack, Athos Bousvaros, Anthony Otley, Jonathan Evans, Mariann Pfefferkorn, Joel Rosh, Robert Rothbaum, Subra Kugathasan, Adam Mezoff, Robert Wyllie, Vasundhara Tolia, J. Fernando delRosario, M. Susan Moyer, Maria Oliva–Hemker, Neal LeLeiko 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 9, Pages (September 2006)
DOI: /j.cgh
Copyright © 2006 American Gastroenterological Association Terms and Conditions

2. Figure 1
Short-term clinical response (change in PGA) after early (<30 days of diagnosis) corticosteroid therapy. CS, corticosteroids; PGA, physician global assessment.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

3. Figure 2
One-year outcome of UC patients treated with CS therapy within 30 days of diagnosis. CS, corticosteroids. *One patient had colectomy within 3 months of diagnosis; 2 patients had colectomy within 3–6 months of diagnosis.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

4. Figure 3
Cumulative probability of colectomy at quarterly intervals for children with UC in the first year after diagnosis. ■, All UC patients (n = 97); •, UC patients who received corticosteroid therapy (n = 77).
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

5. Figure 4
Percent of UC patients receiving early CS therapy who received CS or other selected therapies in follow-up periods. CS, corticosteroids. *Excludes patients with colectomy. ○, CS; ■, mesalamine; ▴, immunomodulators; , infliximab; x, cyclosporine/tacrolimus.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions